| Revenue growth | FY26 turnover at INR 2,140 Cr. |
|---|---|
| Margins | EBITDA margin improved from 6.8% to 10.6% over three years. |
| Demand visibility | Strong; driven by rising demand for nutritious food. |
| Management confidence | High; emphasis on transformation to integrated solution provider. |
Growth
B2C share of premium products rose from 51% (FY23) to 58% (FY26). Gross margin improved 840 bps to 31.5%.
Outlook
FY27 product launches planned including Granuvia and Spinoace. Company targets sustainable value through manufacturing prowess and expanded R&D.
Risks
Challenges include lesser arable land and need for smart farming practices to maintain efficiency.
Last quarter's promises, checked
Delivered
- Guided 25+ products over 3 years → delivered 25+ products (= BEAT)
- Guided Maharatna/Focused share 60-63% → delivered 60-63% (= BEAT)
- Guided FY26 Revenue Growth → delivered 7% YoY growth (= BEAT)
Partly delivered
- Guided 10% export share → delivered 5% (= PARTIAL)
- Guided 120-day WC cycle → delivered 140-150 days (= PARTIAL)
Missed
- Guided PAT growth → delivered slight decline from INR 142Cr to INR 139Cr (= MISS)
Investor Presentation filed with NSE, NSE: INSECTICID. Summary written with AI assistance from the document.
Insecticides (India) Ltd: key numbers
- Share price
- ₹545.25
- Market cap
- ₹1,587 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 13.0×Sector 35.5×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Earnings Call Transcript: Key Takeaways
Q2 revenue rose 8% to ₹686 Cr, but H1 fell 2%, volumes dropped 6-7% and Q2 PAT was ₹56 Cr. Management is upbeat yet hedges on margins, volume recovery and launch timelines.
Insecticides (India) Investor Presentation: Key Takeaways
Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.
Insecticides (India) Results Update
Insecticides (India) released a press release on Q2 and H1 FY27 results. Revenue grew in Q2 while profit after tax declined over the half-year.
Insecticides (India) Dividend
Insecticides (India) declared an interim dividend of Rs.5 per equity share on 5 November 2026 for 2026-2027. Record date is 12 November 2026 and payment is proposed by 17 November 2026.
- Execution
- 2026-2027
Insecticides (India) Q2 FY27 Results: Net Profit ₹56.2 Cr, Down 4.9% YoY
Insecticides (India) Ltd reported revenue from operations of ₹686.3 Cr (+7.6% YoY) and net profit of ₹56.2 Cr (-4.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.2 Cr · -4.9% YoY
Insecticides (India) Board Meeting Date
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.